Prof. Herrmann studied chemistry at the University of Mainz (Germany). From 1997 to 2000 he pursued his graduate studies at the Max Planck Institute for Polymer Research in Mainz. Then he worked as a consultant for Roland Berger Management Consultants in Munich in the department “Pharma and Medicinal Devices” (2001).
In the years 2002 and 2003 he returned to academia working on protein engineering at the Swiss Federal Institute of Technology, Zurich. In 2004, he was appointed as head of a junior research group at the Max Planck Institute for Polymer Research dealing with biological-organic and biological-polymeric hybrid materials. In August 2007, he became an associate professor and in 2010 full professor at the Zernike Institute for Advanced Materials (University of Groningen).
Currently, he is coordinator of a European Research Council-sponsored local training network of 19 PhD students dealing with the development of novel antibiotics. Prof. Andreas Herrmann is co-inventor of AGILeBiotics’ technology and co-founder of the spin-off company. In 2017, he started a position at DWI – Leibniz Institute for Interactive Materials in Aachen, Germany. However, he still holds a honorary appointment at RUG and parts of his research group are still active in Groningen.
AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections